CNS Disorders  >>  Valtoco (diazepam intranasal)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valtoco (diazepam intranasal) / Neurelis, Aculys Pharma
NCT02721069: Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects

Completed
3
175
US
NRL-1, Intranasal diazepam
Neurelis, Inc.
Acute Repetitive Seizures, Breakthrough Seizures
06/20
07/20

Download Options